Recursion Pharmaceuticals, Inc. (RXRX) Tops Q1 EPS by 4c, offers outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: RXRX) | Delayed: 3.51 -0.13 (3.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.64 | 52 Week High | $ | |||
| Open | $3.54 | 52 Week Low | $ | |||
| Day High | $3.68 | P/E | N/A | |||
| Day Low | $3.49 | EPS | $ | |||
| Volume | 11,790,219 | |||||
